美国 · SEC FORM 4
Pelthos Therapeutics Inc.
PTHS · NYSE · CIK 0001919246 · Healthcare · Biotechnology
内部人信号
1 位买方 · 2 条买入交易行 · $999.8K 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ Purchase activity is becoming less recent
- ✓ 角色得分高 · 买入者中职位最高的是：Director
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 53.7
- 53.7
- 53.6
- 53.5
- 53.5
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -8.6%
- 3M
- -21.9%
- 6M
- -9.2%
- 12M
- -24.5%
波动率与流动性
- 波动率
- 145.7%
- Beta
- —
- 平均每日成交额
- USD 1.2M
估值
- 市值
- USD 78.5M
- P/E
- —
基本面
- 利润率
- -257.9%
- ROE
- -111.4%
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, 利润率, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-08-10 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 104,573
- 上期报告
- 93,741
- 日均成交量
- 25,686
- 回补天数
- 4.1
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-11 | Davis Todd C | 买入 (P) | Common Stock | 35,948 | USD 27.81 | USD 999,822 | SEC 申报 ↗ |
| 2024-09-13 | Francis Knuettel II | 买入 (P) | Common Stock | 3,500 | USD 0.97 | USD 3,395 | SEC 申报 ↗ |
| 2024-09-12 | Malamut Richard | 买入 (P) | Common Stock | 10,400 | USD 0.94 | USD 9,776 | SEC 申报 ↗ |
| 2024-09-12 | Francis Knuettel II | 买入 (P) | Common Stock | 1,700 | USD 0.97 | USD 1,649 | SEC 申报 ↗ |
| 2024-09-11 | Francis Knuettel II | 买入 (P) | Common Stock | 5,500 | USD 0.94 | USD 5,170 | SEC 申报 ↗ |
| 2024-09-10 | Francis Knuettel II | 买入 (P) | Common Stock | 6,500 | USD 0.89 | USD 5,785 | SEC 申报 ↗ |
| 2024-02-21 | Friedberg Ezra M | 买入 (P) | Common Stock | 16,667 | USD 6.00 | USD 100,002 | SEC 申报 ↗ |
Form 4 申报证据
30 transaction lines in the latest 365-day window; 47 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Pauls Matthew | 卖出 (S) | Common Stock | 786 | USD 21.00 | USD 16,506 | SEC 申报 ↗ |
| 2026-10-02 | Greenleaf Peter | 卖出 (S) | Common Stock | 797 | USD 21.17 | USD 16,872 | SEC 申报 ↗ |
| 2026-10-02 | Friedberg Ezra M | 卖出 (S) | Common Stock | 558 | USD 20.72 | USD 11,560 | SEC 申报 ↗ |
展开近期 Form 4 证据 (18 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Pauls Matthew | 卖出 (S) | Common Stock | 786 | USD 21.00 | USD 16,506 | SEC 申报 ↗ |
| 2026-10-02 | Greenleaf Peter | 卖出 (S) | Common Stock | 797 | USD 21.17 | USD 16,872 | SEC 申报 ↗ |
| 2026-10-02 | Friedberg Ezra M | 卖出 (S) | Common Stock | 558 | USD 20.72 | USD 11,560 | SEC 申报 ↗ |
| 2026-07-02 | Pauls Matthew | 卖出 (S) | Common Stock | 786 | USD 26.16 | USD 20,564 | SEC 申报 ↗ |
| 2026-07-02 | Greenleaf Peter | 卖出 (S) | Common Stock | 797 | USD 26.14 | USD 20,830 | SEC 申报 ↗ |
| 2026-07-02 | Friedberg Ezra M | 卖出 (S) | Common Stock | 558 | USD 26.09 | USD 14,556 | SEC 申报 ↗ |
| 2026-06-15 | Friedberg Ezra M | 卖出 (S) | Common Stock | 283 | USD 27.29 | USD 7,723 | SEC 申报 ↗ |
| 2026-06-11 | Davis Todd C | 买入 (P) | Common Stock | 35,948 | USD 27.81 | USD 999,822 | SEC 申报 ↗ |
| 2026-05-22 | Francis Knuettel II | 卖出 (S) | Common Stock | 1,500 | USD 26.84 | USD 40,260 | SEC 申报 ↗ |
| 2026-05-22 | Francis Knuettel II | D (D) | Common Stock | 13,947 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | Friedberg Ezra M | 代扣税 (F) | Common Stock | 144 | USD 27.01 | USD 3,889 | SEC 申报 ↗ |
| 2026-04-02 | Pauls Matthew | 卖出 (S) | Common Stock | 786 | USD 20.92 | USD 16,440 | SEC 申报 ↗ |
| 2026-04-02 | Malamut Richard | 卖出 (S) | Common Stock | 590 | USD 20.91 | USD 12,339 | SEC 申报 ↗ |
| 2026-04-02 | Greenleaf Peter | 卖出 (S) | Common Stock | 797 | USD 20.92 | USD 16,671 | SEC 申报 ↗ |
| 2026-04-02 | Friedberg Ezra M | 卖出 (S) | Common Stock | 558 | USD 20.91 | USD 11,670 | SEC 申报 ↗ |
| 2025-12-23 | Einhorn Andrew J. | 奖励／授予 (A) | Common Stock | 12,000 | USD — | USD — | SEC 申报 ↗ |
| 2025-12-10 | Pauls Matthew | 赠与 (G) | Common Stock | 9,542 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-25 | Friedberg Ezra M | 卖出 (S) | Common Stock | 10,000 | USD 28.03 | USD 280,300 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | PTHS |
| CIK | 0001919246 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 47 transaction lines from 2024-02-21 to 2026-10-02 8 P purchase lines · 24 S sale lines · 15 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.